SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network

Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Damian Downey, Lieven Dupont

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

5 Downloads (Pure)

Original language	English
Journal	European Respiratory Journal
Volume	56
Issue number	3
Early online date	06 Aug 2020
DOIs	https://doi.org/10.1183/13993003.02114-2020
Publication status	Early online date - 06 Aug 2020

Access to Document

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
©ERS 2020. This is an open access Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction for non-commercial purposes, provided the author and source are cited.
Final published version, 266 KBLicence: CC BY-NC

@article{2fa351ba87c44ba086507cade41affc7,

title = "SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network",

author = "{van Koningsbruggen-Rietschel}, Silke and Fiona Dunlevy and Veerle Bulteel and Damian Downey and Lieven Dupont",

year = "2020",

month = aug,

day = "6",

doi = "10.1183/13993003.02114-2020",

language = "English",

volume = "56",

journal = "European Respiratory Journal",

issn = "0903-1936",

publisher = "EUROPEAN RESPIRATORY SOC JOURNALS LTD",

number = "3",

}

TY - JOUR

T1 - SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network

AU - van Koningsbruggen-Rietschel, Silke

AU - Dunlevy, Fiona

AU - Bulteel, Veerle

AU - Downey, Damian

AU - Dupont, Lieven

PY - 2020/8/6

Y1 - 2020/8/6

U2 - 10.1183/13993003.02114-2020

DO - 10.1183/13993003.02114-2020

M3 - Article

C2 - 32764115

VL - 56

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 3

ER -